Cardiovascular complications in COVID-19

Brit Long, William J. Brady, Alex Koyfman, Michael Gottlieb

Research output: Contribution to journalReview articlepeer-review

647 Scopus citations


Background: The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and pulmonary complications can result in significant morbidity and mortality, cardiovascular complications may also occur. Objective: This brief report evaluates cardiovascular complications in the setting of COVID-19 infection. Discussion: The current COVID-19 pandemic has resulted in over one million infected worldwide and thousands of death. The virus binds and enters through angiotensin-converting enzyme 2 (ACE2). COVID-19 can result in systemic inflammation, multiorgan dysfunction, and critical illness. The cardiovascular system is also affected, with complications including myocardial injury, myocarditis, acute myocardial infarction, heart failure, dysrhythmias, and venous thromboembolic events. Current therapies for COVID-19 may interact with cardiovascular medications. Conclusions: Emergency clinicians should be aware of these cardiovascular complications when evaluating and managing the patient with COVID-19.

Original languageEnglish (US)
Pages (from-to)1504-1507
Number of pages4
JournalAmerican Journal of Emergency Medicine
Issue number7
StatePublished - Jul 2020


  • Acute myocardial infarction
  • COVID-19
  • Cardiovascular
  • Dysrhythmia
  • Heart failure
  • Infectious disease
  • Myocarditis
  • Troponin

ASJC Scopus subject areas

  • Emergency Medicine


Dive into the research topics of 'Cardiovascular complications in COVID-19'. Together they form a unique fingerprint.

Cite this